ATE425461T1 - Diagnose von hepatozellulärem karzinom - Google Patents

Diagnose von hepatozellulärem karzinom

Info

Publication number
ATE425461T1
ATE425461T1 AT03724724T AT03724724T ATE425461T1 AT E425461 T1 ATE425461 T1 AT E425461T1 AT 03724724 T AT03724724 T AT 03724724T AT 03724724 T AT03724724 T AT 03724724T AT E425461 T1 ATE425461 T1 AT E425461T1
Authority
AT
Austria
Prior art keywords
hepatocellular carcinoma
diagnosis
gpc3
subject
glypican
Prior art date
Application number
AT03724724T
Other languages
English (en)
Inventor
Jorge Filmus
Mariana Capurro
Original Assignee
Sunnybrook & Womens College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29584393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE425461(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sunnybrook & Womens College filed Critical Sunnybrook & Womens College
Application granted granted Critical
Publication of ATE425461T1 publication Critical patent/ATE425461T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03724724T 2002-05-23 2003-05-22 Diagnose von hepatozellulärem karzinom ATE425461T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38234002P 2002-05-23 2002-05-23

Publications (1)

Publication Number Publication Date
ATE425461T1 true ATE425461T1 (de) 2009-03-15

Family

ID=29584393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724724T ATE425461T1 (de) 2002-05-23 2003-05-22 Diagnose von hepatozellulärem karzinom

Country Status (17)

Country Link
US (1) US7883853B2 (de)
EP (1) EP1506406B1 (de)
JP (1) JP4455324B2 (de)
CN (1) CN100401068C (de)
AT (1) ATE425461T1 (de)
AU (1) AU2003229191B2 (de)
BR (1) BRPI0311233B8 (de)
CA (1) CA2482881C (de)
DE (1) DE60326567D1 (de)
ES (1) ES2324029T3 (de)
IL (1) IL164848A0 (de)
MX (1) MXPA04011132A (de)
NZ (1) NZ536521A (de)
PT (1) PT1506406E (de)
RU (1) RU2319969C2 (de)
WO (1) WO2003100429A2 (de)
ZA (1) ZA200410077B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004022597A1 (ja) * 2002-09-04 2004-03-18 Chugai Seiyaku Kabushiki Kaisha Gpc3の血中可溶化ｎ端ﾍﾟﾌﾟﾁﾄﾞに対する抗体
AU2002330482A1 (en) 2002-09-04 2004-03-29 Perseus Proteomics Inc. Method of diagnosing cancer by detecting gpc3
WO2004022595A1 (ja) * 2002-09-04 2004-03-18 Chugai Seiyaku Kabushiki Kaisha MRL/lprマウスを用いた抗体の作製
US7303914B2 (en) * 2003-01-30 2007-12-04 Hongyang Wang Monoclonal antibody against human hepatoma and use thereof
WO2005023301A1 (ja) * 2003-09-04 2005-03-17 Chugai Seiyaku Kabushiki Kaisha 胆管癌治療剤および検出薬
WO2005085861A2 (en) * 2004-03-03 2005-09-15 Oridis Biomed Forschungs- Und Entwicklungs Gmbh Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer
EP1742061A4 (de) 2004-04-28 2007-11-21 Perseus Proteomics Inc Mittel zur vorhersage und beurteilung des wiederauftretens von leberkrebs nach behandlung
SI1674111T1 (sl) * 2004-07-09 2011-02-28 Chugai Pharmaceutical Co Ltd Protitelo proti glipikanu 3
JP4733042B2 (ja) * 2004-08-24 2011-07-27 中外製薬株式会社 抗グリピカン３抗体を用いたアジュバント療法
US20080003623A1 (en) * 2004-10-05 2008-01-03 Atsushi Nakajima Monitoring Agent for Seriousness of Hepatitis
AU2005297772B2 (en) 2004-10-26 2011-06-23 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody having modified sugar chain
US20070087005A1 (en) 2005-10-14 2007-04-19 Lazar Gregory A Anti-glypican-3 antibody
WO2007053659A2 (en) * 2005-11-01 2007-05-10 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of screening for hepatocellular carcinoma
BRPI0909672B1 (pt) * 2008-03-17 2018-09-18 Chugai Seiyaku Kabushiki Kaisha método de imunoensaio in vitro para detecção da presença de células de câncer de fígado em um indivíduo, método para classificação de células de câncer de fígado presentes em um indivíduo, método in vitro para determinação de administrar ou não um agente anticâncer contendo um anticorpo anti-glipicano 3 a um indivíduo, e método in vitro para determinação de uma dose de um agente anticâncer contendo um anticorpo anti-glipicano 3 no tratamento de câncer de fígado em um indivíduo
CN101393217B (zh) * 2008-09-27 2012-05-30 中国人民解放军第二军医大学 一种原发性肝癌血清标志物的检测试剂盒
JP5439494B2 (ja) * 2008-10-21 2014-03-12 バイエル ヘルスケア エルエルシー 肝細胞癌と関連するシグネチャ遺伝子の同定
KR20100098324A (ko) * 2009-02-27 2010-09-06 포항공과대학교 산학협력단 Ｔｍ７ｓｆ３를 유효성분으로 함유하는 간암 진단용 조성물, 및 항 ｔｍ７ｓｆ３ 항체를 유효성분으로 함유하는 간암 진단 키트, 및 간암 예방 또는 치료용 약학 조성물
CN102356316B (zh) 2009-03-05 2015-07-08 独立行政法人产业技术综合研究所 肝内胆管癌的检出、辨别方法
CN102180969B (zh) * 2011-01-30 2013-04-10 中国人民解放军军事医学科学院微生物流行病研究所 抗肝癌活性单克隆抗体及其应用
CN102183660A (zh) * 2011-03-09 2011-09-14 倪温慨 检测Glypican-3的时间分辨免疫荧光试剂盒
CN102353791A (zh) * 2011-06-30 2012-02-15 倪润洲 一种分离检测afp亚型的新方法
EP3557260B1 (de) 2012-12-21 2022-05-18 Chugai Seiyaku Kabushiki Kaisha Gpc3-gerichtetes arzneimittel, das einem patienten verabreicht wird, der auf die gpc3-gerichtete arzneimitteltherapie reagiert
TWI693073B (zh) * 2012-12-21 2020-05-11 日商中外製藥股份有限公司 對ｇｐｃ３標的治療劑療法為有效之患者投與的ｇｐｃ３標的治療劑
WO2014159087A1 (en) * 2013-03-14 2014-10-02 The Board Of Trustees Of The Leland Stanford Junior University Radiolabeled anti-glypican-3 immunoconjugates for immuno-pet imaging of hepatocellular carcinoma
CN105452865A (zh) * 2013-08-06 2016-03-30 金弦起 小肝细胞癌和潜伏于肝硬化的肝细胞癌诊断用组合物
EP3088890B1 (de) 2013-12-24 2020-09-23 Chugai Seiyaku Kabushiki Kaisha Verfahren zur messung von löslichem gpc3-protein
JP6827319B2 (ja) 2014-05-08 2021-02-10 中外製薬株式会社 Ｇｐｃ３標的治療剤療法が有効である患者に投与されるｇｐｃ３標的治療剤
WO2015179658A2 (en) * 2014-05-22 2015-11-26 Genentech, Inc. Anti-gpc3 antibodies and immunoconjugates
MA40764A (fr) 2014-09-26 2017-08-01 Chugai Pharmaceutical Co Ltd Agent thérapeutique induisant une cytotoxicité
KR101704533B1 (ko) * 2014-10-13 2017-02-09 경북대학교병원 간암 바이오마커로서의 ＥＲＲγ 및 이의 용도
JP7096667B2 (ja) 2015-07-01 2022-07-06 中外製薬株式会社 Ｇｐｃ３標的治療剤が有効である患者に投与されるｇｐｃ３標的治療剤
ES2883240T3 (es) * 2015-08-03 2021-12-07 Cafa Therapeutics Ltd Anticuerpo contra glipicano-3 y aplicación del mismo
JP6292564B2 (ja) * 2016-03-10 2018-03-14 シスメックス株式会社 肝細胞がん患者の再発リスク予測を補助する方法、装置、コンピュータプログラム製品及びキット
US11767362B1 (en) 2016-03-15 2023-09-26 Chugai Seiyaku Kabushiki Kaisha Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies
WO2019059411A1 (en) 2017-09-20 2019-03-28 Chugai Seiyaku Kabushiki Kaisha DOSAGE FOR POLYTHERAPY USING PD-1 AXIS BINDING ANTAGONISTS AND GPC3 TARGETING AGENT
AU2022388928A1 (en) 2021-11-16 2024-05-16 Sotio Biotech Inc. Treatment of myxoid/round cell liposarcoma patients
CN114813266B (zh) * 2022-03-15 2025-08-22 中国人民解放军海军军医大学第三附属医院 血液样本中gpc-3复合物的富集、检测方法及应用
KR20260020412A (ko) 2023-06-16 2026-02-11 살루브리스 (청두) 바이오테크 코., 리미티드 항-gpc3 항체 또는 항원 결합 단편 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU218175A (en) * 1974-09-12 1984-04-30 Schwartzhaupt Kg Process for total or individual determination of lactate dehydrogenase isoenzyme
US5171850A (en) * 1988-08-31 1992-12-15 The Ontario Cancer Institute Intestinal oncofetal gene
JP2946216B2 (ja) 1989-07-12 1999-09-06 武田薬品工業株式会社 新規ハイブリドーマ，モノクローナル抗体および用途
EP0477739A3 (en) 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
AU2422999A (en) * 1998-01-27 1999-08-09 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw New members of the glypican gene family
EP1146903A4 (de) * 1998-10-16 2005-02-16 Univ California Glypicane zur detektion und behandlung humaner karzinome
KR100953520B1 (ko) * 2001-06-22 2010-04-21 츄가이 세이야꾸 가부시키가이샤 항글리피칸 3항체를 포함하는 항암제

Also Published As

Publication number Publication date
EP1506406A2 (de) 2005-02-16
ZA200410077B (en) 2005-12-28
CA2482881C (en) 2016-11-08
DE60326567D1 (de) 2009-04-23
BRPI0311233B8 (pt) 2021-07-27
PT1506406E (pt) 2009-06-03
MXPA04011132A (es) 2005-08-15
RU2004136285A (ru) 2005-10-10
RU2319969C2 (ru) 2008-03-20
BRPI0311233A2 (pt) 2016-06-28
CA2482881A1 (en) 2003-12-04
CN1653336A (zh) 2005-08-10
JP4455324B2 (ja) 2010-04-21
EP1506406B1 (de) 2009-03-11
HK1074251A1 (en) 2005-11-04
US7883853B2 (en) 2011-02-08
JP2005526979A (ja) 2005-09-08
WO2003100429A3 (en) 2004-02-19
AU2003229191A1 (en) 2003-12-12
BRPI0311233B1 (pt) 2019-08-13
US20050233392A1 (en) 2005-10-20
IL164848A0 (en) 2005-12-18
WO2003100429A2 (en) 2003-12-04
AU2003229191B2 (en) 2009-07-30
CN100401068C (zh) 2008-07-09
NZ536521A (en) 2006-04-28
ES2324029T3 (es) 2009-07-29

Similar Documents

Publication Publication Date Title
DE60326567D1 (de) Diagnose von hepatozellulärem karzinom
Farzin et al. Recent advances in design of electrochemical affinity biosensors for low level detection of cancer protein biomarkers using nanomaterial-assisted signal enhancement strategies
DK2073008T3 (da) Forbedrede immunoassayfremgangsmåder
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
SE0000538L (sv) Metoder och kit för analytdetektion mha proximitets-probning
JP2008530582A5 (de)
HRP20130127T1 (hr) Prediktivni biomarkeri bubrežne sigurnosti i potpisi biomarkera za praä†enje funkcije bubrega
WO2010011357A3 (en) Detection of prostate cancer using psa glycosylation patterns
EP1708745A4 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE447713T1 (de) S100-proteine und -autoantikörper als serummarker für krebs
RU2011144835A (ru) Способы и композиции на основе белков для диагностики колоректальной аденокарциномы
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
DE602004026869D1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE394675T1 (de) Verfahren zum nachweis von brustkrebs
JP5133842B2 (ja) 癌が疑われる患者または癌患者由来の組織の癌部と非癌部との判別方法およびそれに用いる判別試薬
ATE412180T1 (de) Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
NO20062280L (no) Test
SE0602683L (sv) Diagnostisk metod
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
DE50304756D1 (de) Verfaren zur diagnose von neoplasmen
Toyoda et al. Postinterferon α-fetoprotein elevation and risk of hepatocellular carcinoma development after sustained virological response: cause or results?

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties